Keywords: immunogen, candidates, produce, encouraging, results, massachusetts, usa-based
ImmunoGen's candidates produce "encouraging results"
Article | 17 December 2007
Massachusetts, USA-based biopharmaceutical firm ImmunoGen says that two candidate drugs developed using its Tumor-Activated Prodrug technology have achieved encouraging clinical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
